Abudayyeh said her boss, Caprara, saw a media report about the difficulty a government worker in another state was having obtaining the injectable weight-loss drugs
In fact, Morgan Stanley predicted a widespread adoption rate not unlike the "introduction of smartphones," with 11% of the global eligible population of 1.3 billion people being on some form of a GLP-1 agonist by 2035, including 20% of eligible patients in the US and 10% in other countries
But even if what you read there sounds convincing, its not always medically accurate or helpful
These unregulated products, often sold through unofficial channels or offered by clinics without proper oversight, pose serious risks to users
doi: 10.1001/jamaophthalmol.2025.2332
Verified customer Rated 4.7 Showing our 4 & 5 star reviews